InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (19 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
19
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Klein Matthew B., Directeur et COO. Director active across 2 companies, notably ClearPoint Neuro, Inc.. Cumulatively, 34 filings have been recorded. Breakdown: 0 buy · 19 sells. Total volume traded: €3.8m. History available since 25 June 2021. The latest transaction was disclosed on 4 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Klein Matthew B.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations34 total
10,292 shares@ US$68.570.012% mcap14.5% of flowCommon StockSEC:0001808968-26-000017:0
16,000 shares@ US$11.590.039% mcap100.0% of flowCommon StockSEC:0001193125-26-239431:0
12,417 sharesCommon StockSEC:0001193125-26-234577:0
12,500 shares0Common StockSEC:0001808968-26-000015:0
2,850 shares@ US$70.910.0027% mcap11.0% of flowCommon StockSEC:0001808968-26-000013:0
12,500 shares0Common StockSEC:0001808968-26-000011:0
7,371 shares@ US$69.3614.4% of flowCommon StockSEC:0001808968-26-000009:0
2,514 shares@ US$76.455.5% of flowCommon StockSEC:0001808968-26-000007:0
5,149 shares@ US$76.9511.3% of flowCommon StockSEC:0001808968-26-000005:0
63,000 shares0Common StockSEC:0001808968-26-000003:0
8,089 shares@ US$76.6417.6% of flowCommon StockSEC:0001808968-26-000001:0
15,625 shares0Common StockSEC:0001808968-25-000003:0
75,000 shares0Common StockSEC:0001415889-25-021130:0
21,093 sharesCommon StockSEC:0000950170-25-074448:0
2,804 shares@ US$48.7368.7% of flowCommon StockSEC:0001415889-25-011290:0
3,897 shares@ US$50.09613.5% of flowCommon StockSEC:0001415889-25-005136:0
2,142 shares@ US$45.346.7% of flowCommon StockSEC:0001415889-25-001293:0
70,000 shares0Common StockSEC:0001415889-25-001015:0
8,279 shares@ US$45.1625.9% of flowCommon StockSEC:0001415889-25-000580:0
17,153 sharesCommon StockSEC:0001285550-24-000056:0
3,361 shares@ US$24.8945.7% of flowCommon StockSEC:0001415889-24-011329:0
1,307 shares@ US$25.1352.2% of flowCommon StockSEC:0001415889-24-011247:0
70,000 shares0Common StockSEC:0001415889-24-004106:0
2,237 shares@ US$28.64034.2% of flowCommon StockSEC:0001415889-24-000915:0
10,107 shares@ US$27.148818.1% of flowCommon StockSEC:0001415889-24-000854:0
25 of 34 declarations
About Klein Matthew B.
Klein Matthew B. is Director and COO. He has filed 33 filings in total, and in the recent filings observed between 2021-06-28 and 2026-05-26, all transactions are sales for a total of EUR 3,152,288, with notable sales in PTC Therapeutics, INC. and ClearPoint Neuro, Inc.
